Keyphrases
Blood Pressure
100%
Type 2 Diabetic Patients
100%
Diabetic Subjects
66%
Cardiovascular Events
66%
Risk Factors
33%
Hypertension
33%
Blood Pressure Level
33%
Antihypertensive Drugs
33%
Antihypertensive Therapy
33%
Renin-angiotensin System
33%
Drug Resistance
33%
Type 1 Diabetes Mellitus (T1DM)
33%
Monotherapy
33%
Hypertensive Patients
33%
Volume Overload
33%
Clinical Conditions
33%
Microalbuminuria
33%
Resistance Mechanisms
33%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Non-diabetic
33%
Outcome Trials
33%
Sympathetic Hyperactivity
33%
Sleep Apnea
33%
Suggested Mechanisms
33%
White-coat Hypertension
33%
Poor Compliance
33%
Secondary Hypertension
33%
Goal Blood Pressure
33%
Chymase
33%
Pseudoresistance
33%
Subclinical Depression
33%
Diabetic Hypertension
33%
Angiotensin II Antagonist
33%
Pharmacology, Toxicology and Pharmaceutical Science
Maturity Onset Diabetes of the Young
100%
Renin
50%
Antihypertensive Therapy
50%
Angiotensin
50%
Monotherapy
50%
Diabetes Mellitus
50%
Microalbuminuria
50%
Sleep Disordered Breathing
50%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Drug Resistance
50%
Hyperactivity
50%
White Coat Hypertension
50%
Diabetic Hypertension
50%
Chymase
50%
Subsyndromal Depression
50%
Angiotensin II Antagonist
50%
Antihypertensive Drug
50%
Neuroscience
Diabetes Mellitus
100%
Antihypertensive Agent
100%
Hyperactivity
50%
Drug Resistance
50%
Renin
50%
Obstructive Sleep Apnea
50%
ACE Inhibitor
50%
Angiotensin II
50%
Angiotensin
50%
Subsyndromal Depression
50%
Chymase
50%
Risk Factor
50%
Medicine and Dentistry
Blood Pressure
100%
Patient with Type 2 Diabetes
100%
Cardiovascular System
50%
Antihypertensive Therapy
25%
Renin Angiotensin Aldosterone System
25%
Monotherapy
25%
Obstructive Sleep Apnea
25%
Hyperactivity
25%
Diabetes Mellitus
25%
Drug Resistance
25%
ACE Inhibitor
25%
Volume Overload
25%
White Coat Hypertension
25%
Microalbuminuria
25%
Diabetic Hypertension
25%
Subsyndromal Depression
25%
Chymase
25%
Angiotensin II Antagonist
25%
Antihypertensive Drug
25%
Nursing and Health Professions
Blood Pressure
100%
Patient with Type 2 Diabetes
100%
Antihypertensive Therapy
25%
Renin
25%
Antihypertensive Agent
25%
Angiotensin
25%
Drug Resistance
25%
Monotherapy
25%
Hyperactivity
25%
Sleep Disordered Breathing
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Compliance
25%
Diabetes Mellitus
25%
White Coat Hypertension
25%
Microalbuminuria
25%
Subsyndromal Depression
25%
Diabetic Hypertension
25%
Chymase
25%
Angiotensin II Antagonist
25%